Patents by Inventor Fanny MONCOQ

Fanny MONCOQ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240415951
    Abstract: The present invention relates to a lentiviral vector, in particular a non-integrative lentiviral vector, comprising at least four distinct nucleic acid sequences encoding HPV antigens, to a lentiviral vector particle comprising said vector, to an isolated cell comprising the same, and to a vaccine composition comprising the said lentiviral vector, lentiviral vector particle or cell. The present invention further relates to their implementation in the treatment or prevention of an HPV induced cancer.
    Type: Application
    Filed: November 14, 2022
    Publication date: December 19, 2024
    Inventors: Pierre CHARNEAU, François ANNA, Fanny MONCOQ, Amandine NOIRAT, Laleh MAJLESSI, Laetitia DOUGUET, Ingrid FERT
  • Publication number: 20230364216
    Abstract: The invention relates to a recombinant lentiviral vector genome comprising a polynucleotide encoding a fusion polypeptide, wherein said fusion protein comprises arranged from N-terminal to C-terminal ends: (i) a first polypeptide comprising a multimerization scaffold which comprises at least one collectin or a fragment thereof suitable to enable self-assembly of multimers of the first polypeptide, fused with at least one antigenic polypeptide; (ii) a second polypeptide comprising a CD40L ectodomain or a receptor binding fragment thereof, in particular the CD40L ectodomain of the human CD40L. The invention also relates to a lentiviral vector and pharmaceutical compositions comprising it.
    Type: Application
    Filed: October 15, 2021
    Publication date: November 16, 2023
    Inventors: Pierre CHARNEAU, LALEH MAJLESSI, Jodie LOPEZ, Francois ANNA, Catherine BLANC, Fanny MONCOQ